Intended for healthcare professionals


New law aims to distance the FDA from the drug industry

BMJ 2005; 330 doi: (Published 12 May 2005) Cite this as: BMJ 2005;330:1106
  1. Jeanne Lenzer
  1. New York

    Legislation aimed at ending the close relationship between the US Food and Drug Administration and the drug industry was introduced last week in the House of Representatives by Congressman Maurice Hinchey (Democrat) of New York.

    The Food and Drug Administration Improvement Act 2005 has been endorsed by the Center for Science in the Public Interest in Washington, DC, a non-profit education and advocacy organisation. Merrill Goozner, director of the centre's integrity in science project, said it was “exactly what is needed to restore public confidence in the FDA.”

    The bill includes several provisions aimed at ending financial conflicts of interest. …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription